Life Sciences Newsletter No. 1/2022

Health technology, exports, the new European Regulation on clinical trials, the role of the European Medicines Agency and the legislative changes on Industrial Hemp in Portugal are the themes of this edition.
Newsletters 24/05/2022

In this edition we bring you five important articles:

1. A new era for health technology assessment in the EU;

2. Portugal has more than doubled health exports in the last decade;

3. 2022 – the year of implementation of the new European Clinical Trials Regulation;

4. European Medicines Agency strengthens its role in crisis management;

5. Industrial hemp in Portugal – the most recent legislative changes.

Practice Areas

  • Life Sciences